Global Amyotrophic Lateral Sclerosis Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1366

Amyotrophic lateral sclerosis (ALS) is a group of rare neurological diseases that mainly involve the nerve cells (neurons) responsible for controlling voluntary muscle movement.
Developing medical infrastructure in the emerging economies is expected to drive the growth of Amyotrophic lateral sclerosis market in these economies in the near future.
In 2018, the global Amyotrophic Lateral Sclerosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Amyotrophic Lateral Sclerosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Amyotrophic Lateral Sclerosis development in United States, Europe and China.

The key players covered in this study
GNT Pharma
Synthetic Biologics
Avicena
Amkor Pharma
Mitsubishi Tanabe Pharma
Sanofi
Biogen
Apotex
Mylan Pharmaceuticals

Market segment by Type, the product can be split into
Stem Cell Therapy
Chemotherapy

Market segment by Application, split into
Hospitals
Diagnostic Centres
Clinics
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Amyotrophic Lateral Sclerosis status, future forecast, growth opportunity, key market and key players.
To present the Amyotrophic Lateral Sclerosis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Amyotrophic Lateral Sclerosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Amyotrophic Lateral Sclerosis Market Size Growth Rate by Type (2014-2025)
1.4.2 Stem Cell Therapy
1.4.3 Chemotherapy
1.5 Market by Application
1.5.1 Global Amyotrophic Lateral Sclerosis Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Diagnostic Centres
1.5.4 Clinics
1.5.5 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Amyotrophic Lateral Sclerosis Market Size
2.2 Amyotrophic Lateral Sclerosis Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis Market Size by Regions (2014-2025)
2.2.2 Amyotrophic Lateral Sclerosis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Amyotrophic Lateral Sclerosis Market Size by Manufacturers
3.1.1 Global Amyotrophic Lateral Sclerosis Revenue by Manufacturers (2014-2019)
3.1.2 Global Amyotrophic Lateral Sclerosis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Amyotrophic Lateral Sclerosis Market Concentration Ratio (CR5 and HHI)
3.2 Amyotrophic Lateral Sclerosis Key Players Head office and Area Served
3.3 Key Players Amyotrophic Lateral Sclerosis Product/Solution/Service
3.4 Date of Enter into Amyotrophic Lateral Sclerosis Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Amyotrophic Lateral Sclerosis Market Size by Type (2014-2019)
4.2 Global Amyotrophic Lateral Sclerosis Market Size by Application (2014-2019)

5 United States
5.1 United States Amyotrophic Lateral Sclerosis Market Size (2014-2019)
5.2 Amyotrophic Lateral Sclerosis Key Players in United States
5.3 United States Amyotrophic Lateral Sclerosis Market Size by Type
5.4 United States Amyotrophic Lateral Sclerosis Market Size by Application

6 Europe
6.1 Europe Amyotrophic Lateral Sclerosis Market Size (2014-2019)
6.2 Amyotrophic Lateral Sclerosis Key Players in Europe
6.3 Europe Amyotrophic Lateral Sclerosis Market Size by Type
6.4 Europe Amyotrophic Lateral Sclerosis Market Size by Application

7 China
7.1 China Amyotrophic Lateral Sclerosis Market Size (2014-2019)
7.2 Amyotrophic Lateral Sclerosis Key Players in China
7.3 China Amyotrophic Lateral Sclerosis Market Size by Type
7.4 China Amyotrophic Lateral Sclerosis Market Size by Application

8 Japan
8.1 Japan Amyotrophic Lateral Sclerosis Market Size (2014-2019)
8.2 Amyotrophic Lateral Sclerosis Key Players in Japan
8.3 Japan Amyotrophic Lateral Sclerosis Market Size by Type
8.4 Japan Amyotrophic Lateral Sclerosis Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Amyotrophic Lateral Sclerosis Market Size (2014-2019)
9.2 Amyotrophic Lateral Sclerosis Key Players in Southeast Asia
9.3 Southeast Asia Amyotrophic Lateral Sclerosis Market Size by Type
9.4 Southeast Asia Amyotrophic Lateral Sclerosis Market Size by Application

10 India
10.1 India Amyotrophic Lateral Sclerosis Market Size (2014-2019)
10.2 Amyotrophic Lateral Sclerosis Key Players in India
10.3 India Amyotrophic Lateral Sclerosis Market Size by Type
10.4 India Amyotrophic Lateral Sclerosis Market Size by Application

11 Central & South America
11.1 Central & South America Amyotrophic Lateral Sclerosis Market Size (2014-2019)
11.2 Amyotrophic Lateral Sclerosis Key Players in Central & South America
11.3 Central & South America Amyotrophic Lateral Sclerosis Market Size by Type
11.4 Central & South America Amyotrophic Lateral Sclerosis Market Size by Application

12 International Players Profiles
12.1 GNT Pharma
12.1.1 GNT Pharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Amyotrophic Lateral Sclerosis Introduction
12.1.4 GNT Pharma Revenue in Amyotrophic Lateral Sclerosis Business (2014-2019)
12.1.5 GNT Pharma Recent Development
12.2 Synthetic Biologics
12.2.1 Synthetic Biologics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Amyotrophic Lateral Sclerosis Introduction
12.2.4 Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis Business (2014-2019)
12.2.5 Synthetic Biologics Recent Development
12.3 Avicena
12.3.1 Avicena Company Details
12.3.2 Company Description and Business Overview
12.3.3 Amyotrophic Lateral Sclerosis Introduction
12.3.4 Avicena Revenue in Amyotrophic Lateral Sclerosis Business (2014-2019)
12.3.5 Avicena Recent Development
12.4 Amkor Pharma
12.4.1 Amkor Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Amyotrophic Lateral Sclerosis Introduction
12.4.4 Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis Business (2014-2019)
12.4.5 Amkor Pharma Recent Development
12.5 Mitsubishi Tanabe Pharma
12.5.1 Mitsubishi Tanabe Pharma Company Details
12.5.2 Company Description and Business Overview
12.5.3 Amyotrophic Lateral Sclerosis Introduction
12.5.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Business (2014-2019)
12.5.5 Mitsubishi Tanabe Pharma Recent Development
12.6 Sanofi
12.6.1 Sanofi Company Details
12.6.2 Company Description and Business Overview
12.6.3 Amyotrophic Lateral Sclerosis Introduction
12.6.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Business (2014-2019)
12.6.5 Sanofi Recent Development
12.7 Biogen
12.7.1 Biogen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Amyotrophic Lateral Sclerosis Introduction
12.7.4 Biogen Revenue in Amyotrophic Lateral Sclerosis Business (2014-2019)
12.7.5 Biogen Recent Development
12.8 Apotex
12.8.1 Apotex Company Details
12.8.2 Company Description and Business Overview
12.8.3 Amyotrophic Lateral Sclerosis Introduction
12.8.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Business (2014-2019)
12.8.5 Apotex Recent Development
12.9 Mylan Pharmaceuticals
12.9.1 Mylan Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Amyotrophic Lateral Sclerosis Introduction
12.9.4 Mylan Pharmaceuticals Revenue in Amyotrophic Lateral Sclerosis Business (2014-2019)
12.9.5 Mylan Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details